Biomarkers for primary graft dysfunction after lung transplantation: a review of current evidence and future prospects
Lung transplantation remains the only effective treatment for end-stage lung disease, offering the potential to significantly prolong survival and enhance quality of life for recipients. However, primary graft dysfunction (PGD)-a severe form of lung injury occurring within the first 72 h post-transp...
Saved in:
| Main Authors: | Li Feng, Kelin Luo, Yu Qiu, Rui Li, Chun Xue, Shuaishuai Xi, Jixian Liu, Yuanmin Pei, Chao Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Physiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2025.1557182/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of single versus bilateral lung transplantation on primary graft dysfunction after lung transplantation
by: LIU Zijuan,XU Hongyang
Published: (2025-08-01) -
Use of Impella RP Flex in Post-Heart Transplant Patients with RV Primary Graft Dysfunction
by: Ioana Dumitru, et al.
Published: (2025-05-01) -
LATE DYSFUNCTION OF THE GRAFTED KIDNEY: CAUSES, MORPHOLOGICAL STRUCTURE, PROPHYLAXIS AND TREATMENT
by: E. S. Stolyarevich, et al.
Published: (2009-05-01) -
Prognostic role of levels of extracellular histones H3 for diagnosis of early dysfunction of transplant after hepatic transplantation
by: N. G. Novruzov
Published: (2021-07-01) -
Using a combination of biomarkers to monitor allograft dysfunction in lung transplant recipients
by: Zein Kattih, et al.
Published: (2025-05-01)